
Dover (DOV) Stock
Diversified industrial manufacturer supplying specialized equipment worldwide. Here's the price, business snapshot, and what's worth knowing about Dover in November 2026.
Dover Corporation (NYSE: DOV) is a diversified industrial manufacturer that supplies specialised equipment, components and aftermarket services across multiple end markets. Its operations span engineered systems, pumps & process solutions, imaging & identification and refrigeration & food equipment, among other niches. Dover follows a decentralised operating model and often grows through bolt‑on acquisitions and targeted innovation, aiming to deliver steady free cash flow that can support dividends and share repurchases. Investors should be aware of its exposure to cyclical industrial and retail end markets, which can cause revenue and margin variability as economic conditions shift. Key points to watch include order trends, backlog, margin progression, and management’s capital allocation decisions. This summary is for educational purposes only and not personalised advice; company values can rise as well as fall and past performance is not a reliable indicator of future results.
Why It’s Moving

Dover Targets 25% EBITDA Margin Amid AI-Driven Cost Pressures
- CEO Rich Tobin stated that Dover expects a similar overall business environment in 2027 as it faces current challenges from inflation and labor constraints tied to AI infrastructure spending.
- The company has set a specific target of achieving a 25% EBITDA margin, signaling confidence in operational efficiency despite macroeconomic headwinds.
- Subsidiary CPC Biotech launched the Quattroflow HTX all-in-one pump drive, expanding Dover's footprint in biopharmaceutical processing with new touchscreen control and remote operation features.

Dover Targets 25% EBITDA Margin Amid AI-Driven Cost Pressures
- CEO Rich Tobin stated that Dover expects a similar overall business environment in 2027 as it faces current challenges from inflation and labor constraints tied to AI infrastructure spending.
- The company has set a specific target of achieving a 25% EBITDA margin, signaling confidence in operational efficiency despite macroeconomic headwinds.
- Subsidiary CPC Biotech launched the Quattroflow HTX all-in-one pump drive, expanding Dover's footprint in biopharmaceutical processing with new touchscreen control and remote operation features.
Six-Month Growth Performance
When is the next earnings date for DOVER CORP (DOV)?
The next earnings date for Dover Corporation has not been confirmed yet. Based on the historical reporting pattern of approximately three months after the previous release, the expected timing is late January 2027. This upcoming report will cover the fourth quarter and full-year results for fiscal 2026.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Dover Corp's stock with a target price of $225.6, indicating growth potential.
Financial Health
Dover Corp is performing well with strong profits, cash flow, and revenue, indicating good financial stability.
Dividend
Dover Corp's dividend yield of 0.99% is lower than many other stocks, making it less attractive for dividend-focused investors. If you invested $1000 you would be paid $9.80 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Cashflow & Returns
Dover’s free cash flow has supported dividends and buybacks, appealing to income-focused investors — though payouts depend on company performance and economic cycles.
Innovation & M&A
Bolt‑on acquisitions and product development broaden its technology footprint; successful integration is a key factor in delivering promised benefits.
Cyclical End Markets
Exposure to industrial and retail sectors means performance can swing with the economy; monitor order trends and backlog as early indicators.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.